Smruthi Organics Reports Flat Performance in Q2, PBT Shows Positive Growth

Smruthi Organics, a microcap pharmaceutical company, has recently announced its financial results for the quarter ending September 2024. The company's stock has been given a 'Sell' call by MarketsMOJO.

According to the financial report, Smruthi Organics has shown a flat performance in the second quarter of the fiscal year 2024-2025. However, there has been an improvement in the company's score, which has increased from -10 to 0 in the last three months.

One of the positive aspects of Smruthi Organics' financials is the growth in Profit Before Tax less Other Income (PBT) for the quarter. The PBT has increased by 646.7% to Rs 1.12 crore compared to the average PBT of the previous four quarters, which was Rs 0.15 crore. This shows a very positive trend in the near term.

On the other hand, the company's Profit After Tax (PAT) for the nine-month period has decreased by -72.67% year on year. This indicates a negative trend in the near term for PAT.

Despite the mixed financial results, Smruthi Organics remains a microcap company in the pharmaceutical industry. Investors should carefully consider all factors before making any investment decisions. This information is based solely on the company's financial report and does not include any external data or sources.